Patents Assigned to SRTD BIOTECH GMBH
  • Patent number: 12180470
    Abstract: The present technology comprises methods and RNA constructs for the targeted translation of a polypeptide of interest in a eukaryotic target cell, and to the use thereof in therapeutic clinical applications.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: December 31, 2024
    Assignee: SRTD BIOTECH GMBH
    Inventors: Heribert Bohlen, Bernd Hoffmann